WHY PCOS?
arguable most prev. medical condition in women
What systemic metabolic manifestations are associated with multiple symptomatology? (9)
endocrine, gynaecological, diabetic, dermatological, eating
disorder, psychiatry - complex
Polycystic Ovaries (5)
-increased numbers (>20) of small antral follicles (2-9mm)
= dependent on quality : visible on high quality transvaginal u/s transducers (arranged as necklace of pearls)
There is a disorder of follicle growth at all stages:
– Possibly inc. proportion of primordial follicles & inc. no. of activated (primary) follicles
– Arrested antral follicle growth before they mature
– Lower rates of atresia » antral follicles persist (visible on u/s)
-some cases there is a failure of df selection and therefore anovulation infertility
why are they called cysts?
They are arrested follicles not cysts - just named due to their initial discovery but these differ from ovarian cysts.
PCOS discovery (2)
Described as obesity, hirsutism and anovulation in the presence of bilaterally enlarged sclerocystic (hardened) ovaries
(1935) - Stein + Leventhal
Diagnosis then and now (2)
Then: visuall - biopsies, surgeries, deaths (post mortem)
now: ultrasounds +(transvaginal probe)
spectrum of presentation =Lack of consensus for definition
- now measured using rotterdam criteria POST-EXCLUSION of other disorders
disorders that mimic PCOS/ diagnosis of exclusion: (3)
– Non-classical adrenal hyperplasia (most common is deficiency of 21-hydroxylase → ↑17-hydroxyprogesterone & androgens = PCOS Symp’s)
– Hyperprolactinemia, thyroid disease, Cushing’s syndrome
– Ovarian hyperthecosis (very rare) - nests of luteinized theca cells
Rotterdam Criteria : Diagnosis - need 2 out of 3 criteria (6)
-polycystic ovaries
-Hyper-androgenism
-Ovulatory dysfunction
Polycystic Ovaries: (20 or more follicles measuring 2-9mm diameter and/or increased ovarian volume >10ml in either ovary & no DF >10mm)
-Technique and equipment dependent. T/V imaging not always appropriate
Hyper-androgenism: (clinical (acne/ hair)/biochemical evidence) Assays not
standardized across labs; normative data not clearly defined; clinical hyperandrogenism difficult to quantify; ethnicity
Ovulatory Dysfunction: (Oligomenorrhea/anovulation): Frequent bleeding
<21d or infrequent bleeding >35d.
-To confirm ovulation serum progesterone level at mid-luteal phase (d21-22) of cycle (values ≥7ng/ml needed for regular luteal function)
Polycystic ovary morphology (PCOM) (3)
NORMAL: ≤5 follicles in an ovary with a small amount of stroma early follicular mid-follicular ovulation - then DF emerging + shrunk other follciles
ANOVULATORY PCO: ≥ 20 follicles, 2-9mm diameter arranged necklace follicles around enlarged core of dense stroma - ovarian volume >10mls, with NO df
OVULATORY PCO: scan early = anov. , continue scanning during cycle = emergence of DF but instead of others shrinking + dying - they persist
Refinement of Rotterdam criteria - phenotypes (7)
(table)
A: hyperandro., OD, PCOM
B: hyperandro., OD,
C:hyperandro., PCOM
D: OD, PCOM
Anovulation (4)
What are the candidates for follicle arrest? (4)
– androgens
– intra-follicular inhibitors eg AMH
– defect in apoptosis (follicles that don’t shrink + die)
– dysregulated gonadotrophin secretion (both FSH and LH)
Prevalence of PCO (9)
PCO present in
– 32% of patients with amenorrhoea
– 87% with oligomenorrhoea
– 87% with hirsutism and regular cycles
– 75% of bulimics?
– 22% of ‘normal’ population
-most common cause of anovulatory infertility-73%
Numerous studies since on prevalence:
– PCOM approx. 20%
– PCOS 5-10% depending on definition
PCOS prevalence across populations (4)
Aetiology- genetics (8)
The Chinese Studies (4)
Forced expression of DENND1A.V2 in normal theca cells results in
augmented androgen and progestin production (3)
= DENND1A.V2 overexpression recreated(recapitulated) hyperandrogenic theca cell function (that women w/xs androgen gene have)
PCOS & Gonadotrophins I - LH:FSH(6)
Consistent feature of PCOS is disordered gonadotrophin sec. = downstream ovarian consequences:
– Elevated/upper-normal mean LH
– Low/low-normal FSH
(basically generally see an altered ration of LH:FSH)
– Rapid GnRH frequency → favouring rapid LH pulse secretion
study: 24h LH pulse profiles from control lean and obese women (blue) and lean and obese PCOS women (red).
= Clearly showing increased LH measurements that reflect an increase in LH pulse frequency & amplitude irrespective of body weight (=inherent)
Why does dysregulated gonadotrophin secretion occur? (4)
Impaired negative regulation of GnRH pulse generator because: High T impairs -ve feedback by Proges. in presence of E2
– Proof: block Ar with flutamide → proges. then able to↓ LH & FSH (reinstate function)
– Also see that in late puberty girls without HA respond to proges. w/↓LH pulse frequency overnight, which did not occur in HA girls at same pubertal stage
LH levels in PCOS- graph result
The higher LH will drive thecal cell hyperplasia and the hyper-androgenemia, but HA is also intrinsic and can be independent of LH.
Increased androgens in PCOS (5)
– Most consistent biochemical abnormality w/PCOS: hypersecretion of androgens
– ideal to measure free (T) i.e. SHBG and total testosterone to work out free T
– anov> ov>normal
– increased androgen production by the ovary, even in ovPCO
– Increased LH leads to increased androgen production
Clinical HA signs (2)
– Androgenic alopecia, hirsutism (excess terminal hair) & acne
– consistently reported as most distressing symptoms in
women
testosterone levels & symptoms (6)
normal: 0.5-2.0nmol/L
PCO: higher
Anov: even higher
Anov H: even higher than higher
= increasing T w/ increasing severity of symptoms
≥ 7nmol/L then need to screen for androgen-producing tumour
Explain the MoA of Androgens + hirsutism (4)